Opko Health
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 month.
- Recent price momentum is +14.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation B
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 14.6x | Better than 57% |
| Price / Sales | 1.9x | Better than 59% |
Growth D
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | -15.5% | Better than 4% |
| Net income CAGR (3Y) | 0.0% | Better than 41% |
Profitability D
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 33.9% | Better than 39% |
| Operating margin | -36.1% | Better than 10% |
| Net margin | -37.2% | Better than 10% |
| Return on equity | -17.1% | Better than 17% |
| Return on invested capital | -7.8% | Better than 19% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 6.1% | Better than 85% |
| 6-month return | 23.6% | Better than 86% |
| 12-month return (ex latest month) | 23.5% | Better than 63% |
| Distance below 52-week high | 15.6% | Better than 70% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.0x | Better than 81% |
| Debt to assets | 20.5% | Better than 55% |
| Interest coverage | -1.2x | Better than 21% |
| Free cash flow / net income | 18.9% | Better than 5% |
Analyst View A
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 96.2% | Better than 82% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 1.61
- Open
- 1.57
- Day range
- 1.55 - 1.62
- Avg price
- 1.57
- Volume
- 3.52M
- Turnover
- 5.54M
- Turnover ratei
- 1.10%
- Volume ratioi
- 1.29
- Amplitudei
- 4.66%
- 52-week rangei
- 0.98 - 1.86
Valuation
- P/Ei
- -5.23
- P/E (TTM)i
- -7.85
- P/Bi
- 1.04
- EPSi
- -0.30
- Book value / shi
- 1.50
- Net profit
- -222.75M
- Net assets
- 1.12B
Share structure
- Market cap
- 1.17B
- Float capi
- 502.27M
- Shares out
- 742.51M
- Float sharesi
- 319.92M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
15.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-4.06M net over the window
Short interest
- Shares short
- 32.85M
- % of floati
- 4.40%
- Days to coveri
- 9.23
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Opko Health (OPK)?
Opko Health last traded at 1.57. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Opko Health's market cap?
About 1.17B.
What is the P/E ratio of Opko Health?
The trailing twelve-month P/E is -7.85. The Valuation tab shows it against the stock's own five-year range.
Does Opko Health pay a dividend?
Opko Health does not currently pay a regular dividend.
Is Opko Health a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 3.08, which implies 96.2% upside from the current price. This is not investment advice.
What is Opko Health's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Opko Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:36 · For reference only, not investment advice and not tailored to your situation.
Opko Health discussion 0 comments